| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. S Yusuf, P Sleight, J Pogue, J Bosch, R Davies, G Dagenais The New England journal of medicine 342 (3), 145-153, 2000 | 8649 | 2000 |
| Rivaroxaban with or without aspirin in stable cardiovascular disease JW Eikelboom, SJ Connolly, J Bosch, GR Dagenais, RG Hart, ... New England Journal of Medicine 377 (14), 1319-1330, 2017 | 2621 | 2017 |
| Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ... The Lancet 368 (9541), 1096-1105, 2006 | 2261 | 2006 |
| Vitamin E supplementation and cardiovascular events in high-risk patients. S Yusuf, G Dagenais, J Pogue, J Bosch, P Sleight The New England journal of medicine 342 (3), 154-160, 2000 | 2026 | 2000 |
| Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial JFE Mann, HC Gerstein, J Pogue, J Bosch, S Yusuf, Hope Investigators Annals of internal medicine 134 (8), 629-636, 2001 | 1894 | 2001 |
| Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. E Lonn, J Bosch, S Yusuf, P Sheridan, J Pogue, JM Arnold, C Ross, ... Jama 293 (11), 1338-1347, 2005 | 1502 | 2005 |
| Guidelines for critical review of qualitative studies M Law, D Stewart, L Letts, N Pollock, J Bosch, M Westmorland McMaster University occupational therapy evidence-based practice research …, 1998 | 1274 | 1998 |
| n–3 fatty acids and cardiovascular outcomes in patients with dysglycemia ORIGIN Trial Investigators New England Journal of Medicine 367 (4), 309-318, 2012 | 1160 | 2012 |
| Cholesterol lowering in intermediate-risk persons without cardiovascular disease S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ... New England Journal of Medicine 374 (21), 2021-2031, 2016 | 1083 | 2016 |
| Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE) EM Lonn, S Yusuf, V Dzavik, CI Doris, Q Yi, S Smith, A Moore-Cox, ... Circulation 103 (7), 919-925, 2001 | 1078 | 2001 |
| Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes F Botto, P Alonso-Coello, MTV Chan, JC Villar, D Xavier, S Srinathan, ... Anesthesiology 120 (3), 564-578, 2014 | 1018 | 2014 |
| Effect of ramipril on the incidence of diabetes DREAM Trial Investigators New England Journal of Medicine 355 (15), 1551-1562, 2006 | 1004 | 2006 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 998 | 2018 |
| Blood-pressure lowering in intermediate-risk persons without cardiovascular disease EM Lonn, J Bosch, P López-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ... New England Journal of Medicine 374 (21), 2009-2020, 2016 | 838 | 2016 |
| Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals T Aung, J Halsey, D Kromhout, HC Gerstein, R Marchioli, L Tavazzi, ... JAMA cardiology 3 (3), 225-233, 2018 | 794 | 2018 |
| Ramipril and the development of diabetes S Yusuf, H Gerstein, B Hoogwerf, J Pogue, J Bosch, BHR Wolffenbuttel, ... Jama 286 (15), 1882-1885, 2001 | 769 | 2001 |
| Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril J Mathew, P Sleight, E Lonn, D Johnstone, J Pogue, Q Yi, J Bosch, ... Circulation 104 (14), 1615-1621, 2001 | 758 | 2001 |
| Use of ramipril in preventing stroke: double blind randomised trial J Bosch, S Yusuf, J Pogue, P Sleight, E Lonn, B Rangoonwala, R Davies, ... Bmj 324 (7339), 699, 2002 | 703 | 2002 |
| Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease GR Dagenais, Q Yi, JFE Mann, J Bosch, J Pogue, S Yusuf, ... American heart journal 149 (1), 54-60, 2005 | 574 | 2005 |
| Blood-pressure and cholesterol lowering in persons without cardiovascular disease S Yusuf, E Lonn, P Pais, J Bosch, P Lopez-Jaramillo, J Zhu, D Xavier, ... New England Journal of Medicine 374 (21), 2032-2043, 2016 | 510 | 2016 |
